2019
DOI: 10.1136/ejhpharm-2018-001746
|View full text |Cite
|
Sign up to set email alerts
|

Current situation of carboplatin desensitisation protocols in the hospitals of Spain

Abstract: Desensitisation protocols allow the continuation of treatment in patients who have presented hypersensitivity reactions. Carboplatin desensitisation solutions are usually prepared in the chemotherapy centralised units of hospital pharmacies and they are diluted under the established concentration limit to guarantee the stability of the preparation. An online survey was sent to hospital pharmacies, inquiring about local desensitisation protocols: reasons for use of desensitisation protocols, the protocols used … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…The desensitization procedure requires continuous exposure to the drug; therefore, it involves the implementation of multi-stage protocols, assuming the administration of drug solutions of different concentrations with increasing doses and flow rates [35,52]. It is necessary to maintain constant intervals of 15-20 min in order to stabilize the pharmacokinetics of the drug.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The desensitization procedure requires continuous exposure to the drug; therefore, it involves the implementation of multi-stage protocols, assuming the administration of drug solutions of different concentrations with increasing doses and flow rates [35,52]. It is necessary to maintain constant intervals of 15-20 min in order to stabilize the pharmacokinetics of the drug.…”
Section: Methodsmentioning
confidence: 99%
“…The most common is the 12-step protocol with three bags of solution. Most protocols allow the full therapeutic dose to be administered in 4-12 h, although this may be extended in the event of a breakthrough reaction (BTR) [44,45,52,53]. The procedure requires individualization-in patients at high risk of anaphylaxis, 16-and 20-step protocols are proposed to minimize it, while in patients with HSR grades I and II, a 12-step protocol is most often implemented [51,54].…”
Section: Methodsmentioning
confidence: 99%